A report into price gouging and unfair pricing practices developed by Professor Allan Fels and initiated by the ACTU has recommended measures to monitor pharmaceutical companies more closely.
Report recommends mandatory reporting of arrangements despite no evidence they exist
February 8, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Another day, and another example of our system's shortcomings
July 21, 2025 - - Latest News -
Companies have all the power in this process, if they choose to use it
July 21, 2025 - - Latest News -
Trump says countries will avoid tariffs if manufacturing returns to the US
July 21, 2025 - - Latest News -
Mesoblast updates investors on the succesful US launch of cell medicine
July 20, 2025 - - Australian Biotech -
Company refuses FDA request to halt distribution of gene therapy
July 20, 2025 - - Latest News -
Australian researcher awarded Gilead Sciences global grant to explore novel approach in breast cancer
July 18, 2025 - - Latest News -
The 'Dispatched' Week in Review Podcast - 17 July
July 17, 2025 - - Podcast